Annual Interest Expense
$27.16 M
+$25.31 M+1371.18%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual interest expense is currently $27.16 million, with the most recent change of +$25.31 million (+1371.18%) on 31 December 2023. During the last 3 years, it has risen by +$26.78 million (+7161.50%). AMPH annual interest expense is now at all-time high.AMPH Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$6.70 M
-$1.91 M-22.20%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly interest expense is currently $6.70 million, with the most recent change of -$1.91 million (-22.20%) on 30 September 2024. Over the past year, it has dropped by -$7.00 million (-51.12%). AMPH quarterly interest expense is now -51.12% below its all-time high of $13.70 million, reached on 30 September 2023.AMPH Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$33.37 M
-$7.00 M-17.35%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM interest expense is currently $33.37 million, with the most recent change of -$7.00 million (-17.35%) on 30 September 2024. Over the past year, it has increased by +$15.14 million (+83.07%). AMPH TTM interest expense is now -17.35% below its all-time high of $40.38 million, reached on 30 June 2024.AMPH TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1371.2% | -51.1% | +83.1% |
| 3 y3 years | +7161.5% | +1171.0% | +4045.8% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
AMPH Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +7161.5% | -51.1% | +3886.9% | -17.4% | +4045.8% |
| 5 y | 5 years | at high | >+9999.0% | -51.1% | >+9999.0% | -17.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -51.1% | +1317.8% | -17.4% | >+9999.0% |
Amphastar Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.70 M(-22.2%) | $33.37 M(-17.3%) |
| June 2024 | - | $8.61 M(-0.0%) | $40.38 M(+14.2%) |
| Mar 2024 | - | $8.61 M(-8.9%) | $35.37 M(+30.2%) |
| Dec 2023 | $27.16 M(+1371.2%) | $9.46 M(-31.0%) | $27.16 M(+49.0%) |
| Sept 2023 | - | $13.70 M(+280.4%) | $18.23 M(+257.9%) |
| June 2023 | - | $3.60 M(+805.0%) | $5.09 M(+169.7%) |
| Mar 2023 | - | $398.00 K(-24.6%) | $1.89 M(+2.3%) |
| Dec 2022 | $1.85 M(+108.6%) | $528.00 K(-6.7%) | $1.85 M(+24.2%) |
| Sept 2022 | - | $566.00 K(+42.6%) | $1.49 M(+2.7%) |
| June 2022 | - | $397.00 K(+11.8%) | $1.45 M(+27.4%) |
| Mar 2022 | - | $355.00 K(+111.3%) | $1.14 M(+28.4%) |
| Dec 2021 | $885.00 K(+136.6%) | $168.00 K(-68.1%) | $885.00 K(+9.9%) |
| Sept 2021 | - | $527.00 K(+512.8%) | $805.00 K(+77.7%) |
| June 2021 | - | $86.00 K(-17.3%) | $453.00 K(+12.7%) |
| Mar 2021 | - | $104.00 K(+18.2%) | $402.00 K(+7.5%) |
| Dec 2020 | $374.00 K(+214.3%) | $88.00 K(-49.7%) | $374.00 K(+13.7%) |
| Sept 2020 | - | $175.00 K(+400.0%) | $329.00 K(+86.9%) |
| June 2020 | - | $35.00 K(-53.9%) | $176.00 K(+6.7%) |
| Mar 2020 | - | $76.00 K(+76.7%) | $165.00 K(+38.7%) |
| Dec 2019 | $119.00 K(-51.0%) | $43.00 K(+95.5%) | $119.00 K(+54.5%) |
| Sept 2019 | - | $22.00 K(-8.3%) | $77.00 K(-57.0%) |
| June 2019 | - | $24.00 K(-20.0%) | $179.00 K(-29.8%) |
| Mar 2019 | - | $30.00 K(+2900.0%) | $255.00 K(+4.9%) |
| Dec 2018 | $243.00 K | $1000.00(-99.2%) | $243.00 K(-35.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $124.00 K(+24.0%) | $376.00 K(-27.1%) |
| June 2018 | - | $100.00 K(+455.6%) | $516.00 K(-21.0%) |
| Mar 2018 | - | $18.00 K(-86.6%) | $653.00 K(-20.9%) |
| Dec 2017 | $826.00 K(-19.3%) | $134.00 K(-49.2%) | $826.00 K(+10.7%) |
| Sept 2017 | - | $264.00 K(+11.4%) | $746.00 K(-2.2%) |
| June 2017 | - | $237.00 K(+24.1%) | $763.00 K(-8.2%) |
| Mar 2017 | - | $191.00 K(+253.7%) | $831.00 K(-18.8%) |
| Dec 2016 | $1.02 M(+3.7%) | $54.00 K(-80.8%) | $1.02 M(-12.8%) |
| Sept 2016 | - | $281.00 K(-7.9%) | $1.17 M(+4.4%) |
| June 2016 | - | $305.00 K(-20.6%) | $1.13 M(+9.2%) |
| Mar 2016 | - | $384.00 K(+88.2%) | $1.03 M(+4.4%) |
| Dec 2015 | $987.00 K(+62.1%) | $204.00 K(-12.1%) | $987.00 K(+323.6%) |
| Sept 2015 | - | $232.00 K(+10.5%) | $233.00 K(-53.9%) |
| June 2015 | - | $210.00 K(-38.4%) | $505.00 K(-34.5%) |
| Mar 2015 | - | $341.00 K(-162.0%) | $771.00 K(+26.4%) |
| Dec 2014 | $609.00 K(-36.4%) | -$550.00 K(-209.1%) | $610.00 K(-55.8%) |
| Sept 2014 | - | $504.00 K(+5.9%) | $1.38 M(+28.8%) |
| June 2014 | - | $476.00 K(+164.4%) | $1.07 M(+28.7%) |
| Mar 2014 | - | $180.00 K(-18.6%) | $833.00 K(-13.0%) |
| Dec 2013 | $958.00 K(+22.2%) | $221.00 K(+13.3%) | $958.00 K(+30.0%) |
| Sept 2013 | - | $195.00 K(-17.7%) | $737.00 K(+36.0%) |
| June 2013 | - | $237.00 K(-22.3%) | $542.00 K(+77.7%) |
| Mar 2013 | - | $305.00 K | $305.00 K |
| Dec 2012 | $784.00 K(+34.2%) | - | - |
| Dec 2011 | $584.00 K | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual interest expense year-on-year change?
- What is Amphastar Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly interest expense year-on-year change?
- What is Amphastar Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM interest expense year-on-year change?
What is Amphastar Pharmaceuticals annual interest expense?
The current annual interest expense of AMPH is $27.16 M
What is the all time high annual interest expense for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual interest expense is $27.16 M
What is Amphastar Pharmaceuticals annual interest expense year-on-year change?
Over the past year, AMPH annual interest expense has changed by +$25.31 M (+1371.18%)
What is Amphastar Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of AMPH is $6.70 M
What is the all time high quarterly interest expense for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly interest expense is $13.70 M
What is Amphastar Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, AMPH quarterly interest expense has changed by -$7.00 M (-51.12%)
What is Amphastar Pharmaceuticals TTM interest expense?
The current TTM interest expense of AMPH is $33.37 M
What is the all time high TTM interest expense for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM interest expense is $40.38 M
What is Amphastar Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, AMPH TTM interest expense has changed by +$15.14 M (+83.07%)